BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)BALA CYNWYD, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
SVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Servotronics, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Servotronics, Inc. (
NYSE: SVT) to TransDigm Group Incorporated for $38.50 per share in cash is fair to Servotronics shareholders.
Shareholder Alert: The Ademi Firm investigates whether Servotronics, Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Servotronics (NYSE American: SVT) for possible breaches of fiduciary duty and other violations of law in its transaction with TransDigm.
